Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

May 08, 2007

A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.

"Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors," says review author Dr. Siqing Fu, an assistant professor of oncology at the University of Texas at Houston. "However, more research is needed to determine whether combining molecular-targeted therapy with hormonal therapy would be a more effective option."

Ovarian cancer is the deadliest of gynecological cancers; approximately 70 percent of patients are diagnosed in the later stages, when the 5-year survival rate drops below 25 percent. Traditional chemotherapy has proven to be generally ineffective against recurrent ovarian cancer, which has led researchers to investigate novel treatments.

"While a cure is unlikely, the goals of treatment are to control tumor-related symptoms and to improve or maintain quality of life," says Dr. Fu. "After surveying the latest research, combined molecular-targeted and hormonal therapy offers the greatest promise in achieving these goals and therefore deserves further investigation."

Source: Blackwell Publishing Ltd.

Explore further: The 'Angelina Effect' was not only immediate, but also long-lasting

add to favorites email to friend print save as pdf

Related Stories

Rio's Olympic golf course in legal bunker

3 hours ago

The return of golf to the Olympics after what will be 112 years by the time Rio hosts South America's first Games in 2016 comes amid accusations environmental laws were got round to build the facility in ...

Alibaba prices IPO at $68 per share

4 hours ago

Alibaba, the Chinese e-commerce powerhouse named after a fabled, poor woodsman who discovers a thieves' den full of treasures, is ready to strike it rich on the New York Stock Exchange.

Recommended for you

User comments : 0